ISCA2
Basic information
Region (hg38): 14:74493756-74497106
Previous symbols: [ "HBLD1" ]
Links
Phenotypes
GenCC
Source:
- multiple mitochondrial dysfunctions syndrome 4 (Strong), mode of inheritance: AR
- multiple mitochondrial dysfunctions syndrome 4 (Moderate), mode of inheritance: AR
- multiple mitochondrial dysfunctions syndrome 4 (Strong), mode of inheritance: AR
- multiple mitochondrial dysfunctions syndrome 4 (Supportive), mode of inheritance: AR
- mitochondrial disease (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Multiple mitochondrial dysfunctions syndrome 4 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing; Variants may additionally act as susceptibility factors (rather than being involved in Mendelian-inherited dominant disease) | Biochemical; Musculoskeletal; Neurologic; Ophthalmologic | 25539947 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ISCA2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 14 | ||||
missense | 26 | 29 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 1 | 4 | |||
non coding | 13 | |||||
Total | 1 | 3 | 31 | 24 | 2 |
Highest pathogenic variant AF is 0.0000394
Variants in ISCA2
This is a list of pathogenic ClinVar variants found in the ISCA2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-74493769-A-C | not specified | Likely benign (Jun 02, 2016) | ||
14-74493795-G-C | Likely benign (Oct 17, 2023) | |||
14-74493798-C-T | Likely benign (Nov 01, 2022) | |||
14-74493800-T-A | Uncertain significance (May 06, 2024) | |||
14-74493803-C-T | Uncertain significance (Aug 23, 2021) | |||
14-74493807-C-G | Likely benign (Jul 22, 2023) | |||
14-74493808-GCGA-G | Uncertain significance (Jun 01, 2023) | |||
14-74493825-C-A | Likely benign (Dec 03, 2021) | |||
14-74493829-C-T | Inborn genetic diseases | Uncertain significance (Feb 06, 2024) | ||
14-74493836-C-T | Uncertain significance (Dec 11, 2023) | |||
14-74493841-G-C | Uncertain significance (Jun 07, 2022) | |||
14-74493848-A-T | Multiple mitochondrial dysfunctions syndrome 4 | Uncertain significance (Mar 29, 2024) | ||
14-74493853-G-A | ISCA2-related disorder | Likely benign (Jan 07, 2020) | ||
14-74493855-C-T | Likely benign (Oct 25, 2021) | |||
14-74493876-G-T | Likely benign (Jul 10, 2018) | |||
14-74494030-C-T | Likely benign (Aug 04, 2023) | |||
14-74494045-C-T | Likely benign (Oct 24, 2020) | |||
14-74494053-C-T | Likely benign (Mar 31, 2021) | |||
14-74494056-C-T | Likely benign (May 29, 2022) | |||
14-74494061-C-T | ISCA2-related disorder | Conflicting classifications of pathogenicity (Feb 13, 2024) | ||
14-74494064-C-T | Uncertain significance (Jan 04, 2024) | |||
14-74494082-G-T | Uncertain significance (May 09, 2024) | |||
14-74494089-G-A | Likely benign (May 06, 2022) | |||
14-74494090-G-A | Inborn genetic diseases | Uncertain significance (Aug 12, 2024) | ||
14-74494094-C-A | Likely pathogenic (Jun 25, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ISCA2 | protein_coding | protein_coding | ENST00000556816 | 4 | 3387 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.43e-8 | 0.0445 | 125725 | 0 | 23 | 125748 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.384 | 71 | 80.7 | 0.880 | 0.00000366 | 971 |
Missense in Polyphen | 20 | 25.615 | 0.78078 | 319 | ||
Synonymous | -1.12 | 43 | 34.6 | 1.24 | 0.00000165 | 318 |
Loss of Function | -1.01 | 10 | 7.09 | 1.41 | 3.54e-7 | 75 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000235 | 0.000235 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000229 | 0.000217 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000793 | 0.0000791 |
Middle Eastern | 0.000229 | 0.000217 |
South Asian | 0.00 | 0.00 |
Other | 0.000354 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the maturation of mitochondrial 4Fe-4S proteins functioning late in the iron-sulfur cluster assembly pathway. May be involved in the binding of an intermediate of Fe/S cluster assembly. {ECO:0000269|PubMed:22323289}.;
- Disease
- DISEASE: Multiple mitochondrial dysfunctions syndrome 4 (MMDS4) [MIM:616370]: A severe disorder of systemic energy metabolism, resulting in weakness, respiratory failure, lack of neurologic development, lactic acidosis, hyperglycinemia and early death. {ECO:0000269|PubMed:25539947}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Mitochondrial iron-sulfur cluster biogenesis;Metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.530
- rvis_EVS
- 0.08
- rvis_percentile_EVS
- 59.43
Haploinsufficiency Scores
- pHI
- 0.133
- hipred
- N
- hipred_score
- 0.239
- ghis
- 0.607
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Isca2
- Phenotype
Gene ontology
- Biological process
- iron-sulfur cluster assembly;small molecule metabolic process;protein maturation;protein maturation by iron-sulfur cluster transfer;protein maturation by [4Fe-4S] cluster transfer
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- structural molecule activity;iron ion binding;protein binding;2 iron, 2 sulfur cluster binding;4 iron, 4 sulfur cluster binding